Virax Biolabs Group Ltd Class A ($VRAX) has been mentioned 8 times over the past 12 months by 2 distinct FinTwit voices, with the first mention appearing on April 13, 2026. The most recent discussion occurred on July 10, 2026. Antonio Costa (@acinvestorblog) accounts for 6 of these mentions, while InvestmentGuru (@investmentguru_) contributed 2 mentions, with long research categorized as the dominant voice category for this ticker.

The most recent conversation centered on Virax's cash position following a preferred investment closing. On July 10, 2026, @acinvestorblog noted that the company should have approximately $6–6.5 million in cash based on a $3.3 million gross proceeds closing announcement. The same voice observed that $VRAX was trading at nearly 50% below its cash position with trading volume of 1.4 million shares on that day.